Oragenics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Oragenics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Oragenics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Oragenics Inc. is OGEN:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Oragenics Inc. has its primary listing on NYSE American. You can trade Oragenics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Oragenics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Oragenics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Oragenics Inc..